Lawrence Mulligan | Cardiac Physiology | Innovative Research Award

Innovative Research Award

Lawrence Mulligan
Cooper University Hospital and CMSRU, United States
Lawrence Mulligan
Affiliation Cooper University Hospital and CMSRU
Country United States
Scopus ID 59848042500
Documents 4
Citations 3
h-index 1
Subject Area Cardiac Physiology
Event International Academic Achievements & Awards

Lawrence J. Mulligan, PhD, FAHA, is a cardiovascular physiology and medical device innovation specialist with more than twenty-five years of experience spanning translational physiology, computational cardiovascular modeling, scientific communications, clinical evidence generation, and cardiovascular technology strategy. His work integrates physiological science, device analytics, computational mechanics, and translational cardiovascular research to support advancement of cardiac technologies and clinical adoption pathways.[1]

Abstract

Lawrence J. Mulligan has contributed to cardiovascular science through work involving computational ventricular mechanics, translational physiology, cardiovascular device analytics, myocardial energetics, electromechanical cardiac behavior, and non-invasive cardiac function assessment. His scientific and leadership activities bridge academia, healthcare institutions, and cardiovascular technology industries, emphasizing evidence generation strategies and scientific advancement supporting cardiovascular innovation.[2]

Keywords

Cardiovascular Physiology; Computational Hemodynamics; Medical Science Liaison; Cardiac Device Innovation; Translational Research; Electromechanical Cardiac Modeling; Heart Failure Therapy; Cardiac Rhythm Management; Clinical Evidence Generation; Cardiovascular Analytics

Introduction

The evolution of cardiovascular medicine increasingly depends upon translational science, computational physiology, and device innovation capable of improving patient outcomes through precision diagnostics and therapeutic technologies. Lawrence J. Mulligan has developed expertise across cardiovascular physiology and medical device strategy while contributing to scientific translation and clinical adoption initiatives associated with cardiac technologies.[3]

Research Profile

  • Director of Research, Department of Anesthesiology, Cooper University Healthcare
  • Associate Professor, Anesthesiology, Cooper Medical School of Rowan University
  • Adjunct Professor, Biomedical Engineering, University of North Dakota
  • Former Senior Principal Scientist, Medical Science Liaison, and Technical Fellow at Medtronic
  • Fellow of the American Heart Association
  • PhD in Cardiac and Systems Physiology from Texas A&M University

Research Contributions

Research contributions by Lawrence J. Mulligan include computational cardiovascular modeling, ventricular mechanics, force-frequency physiology modeling, myocardial efficiency assessment, hemodynamic analytics, cardiac rhythm management science, and translational physiology applications supporting device development and clinical evaluation frameworks.[4]

His work has included development of methodologies focused on non-invasive cardiovascular measurements, vascular aging assessments, myocardial efficiency quantification, ventricular-vascular coupling analysis, and computational approaches informing cardiovascular device innovation and performance evaluation.[5]

Professional leadership activities further include scientific communication programs, key opinion leader engagement strategies, device adoption initiatives, and mentoring programs supporting engineering and medical trainees.

Publications

Publications by Lawrence J. Mulligan, reflect extensive contributions to cardiovascular physiology, computational hemodynamics, cardiac mechanics, and cardiovascular device innovation. His scholarly work focuses on ventricular function, myocardial efficiency, cardiac resynchronization therapy, vascular aging, and non-invasive cardiovascular assessment methodologies. Through peer-reviewed research and translational science, his publications have supported advancements in cardiovascular technology development, clinical decision-making, and evidence-based strategies for improving cardiac device performance and patient outcomes.

Research Impact

Lawrence J. Mulligan’s activities span academic institutions, healthcare systems, and cardiovascular technology industries. Contributions include cardiovascular device analytics development, scientific evidence communication, patent generation, mentoring initiatives, translational physiology leadership, and participation in device-oriented innovation frameworks. Patent contributions include granted and pending intellectual property associated with cardiac sensing, myocardial analytics, electromechanical modeling, and cardiovascular function algorithms.

Research funding involvement exceeds four hundred thousand dollars through grants and research leadership activities spanning cardiovascular physiology and device evaluation domains.

Award Suitability

The academic and scientific portfolio demonstrates characteristics associated with recognition frameworks emphasizing interdisciplinary innovation, translational biomedical science, medical device advancement, intellectual property development, scientific leadership, and evidence-based cardiovascular research contributions. Sustained engagement across healthcare, industry, and academic environments supports consideration within scientific recognition initiatives.

Conclusion

Lawrence J. Mulligan’s work reflects integration of physiology research, computational science, cardiovascular innovation, and translational medical strategy. His professional trajectory demonstrates sustained contributions to cardiovascular technology advancement through scientific leadership, device analytics, translational modeling, and interdisciplinary collaboration supporting cardiovascular medicine and clinical innovation.

References

  1. Professional curriculum vitae and academic information supplied for scholarly profile preparation.
  2. Mulligan LJ. Translational cardiovascular physiology and computational cardiac modeling contributions.
  3. Cardiovascular innovation leadership and medical device translational science documentation.
  4. Evaluation of Ventricular-Vascular Coupling with Critical Care Metrics. Physiological Reports, 2024.
  5. Evaluation of Vascular Aging on Measures of Cardiac Function and Mechanical Efficiency. Frontiers in Cardiovascular Medicine, 2024.

Mohamed Elnaggar | Lipidology | Best Researcher Award

Dr. Mohamed Elnaggar | Lipidology | Best Researcher Award

Consultant Endocrinologist and Physician at Royal Lancaster Infirmary, United Kingdom

Dr. Mohamed Nabil Elnaggar is an esteemed consultant and researcher specializing in diabetes, endocrinology, and lipidology. With a career spanning various prestigious institutions, he is recognized for his clinical expertise and contributions to medical research. Dr. Elnaggar’s work integrates extensive clinical practice with innovative research, enhancing patient care and advancing the field of endocrinology. He is currently a leading figure in lipidology and diabetes management, holding significant roles in both clinical and academic settings.

Profile

GOOGLE SCHOLAR

Education

Dr. Elnaggar’s academic journey is marked by an impressive array of qualifications. He completed his MBChB at Alexandria University with honors and pursued further studies to earn an MSc and a PhD in Internal Medicine from Alexandria Faculty of Medicine. His postgraduate education includes obtaining membership of the Royal College of Physicians (MRCP UK) and a Subspecialty certificate in Diabetes and Endocrinology. He has also maintained current expertise through multiple certifications in Good Clinical Practice (GCP).

Experience

Dr. Elnaggar has extensive clinical experience across various hospitals and institutions. He has worked as an Internal Medicine Specialist and Consultant in several renowned facilities, including Alexandria Main University Hospital and University Hospitals of Morecambe Bay. His roles have included leading the Diabetes and Endocrinology Unit and the Lipid service. In addition to his clinical work, he has served as a lecturer and consultant, contributing to both the education of future medical professionals and the advancement of clinical practice.

Research Interest

Dr. Elnaggar’s research interests lie primarily in diabetes management, lipid disorders, and endocrinology. His work focuses on improving treatment strategies for complex conditions such as familial dyslipidemias and type 2 diabetes, particularly in the context of Ramadan fasting and new therapeutic interventions. He is involved in a variety of clinical trials and research studies aimed at enhancing understanding and management of these conditions.

Awards

Dr. Elnaggar has been recognized for his contributions to the field of medicine through various accolades and awards. His dedication to research and clinical excellence has been acknowledged by his peers and the broader medical community, highlighting his role as a leading researcher and clinician in diabetes and lipidology.

Publications

Primary Hyperparathyroidism: Findings from the Retrospective Evaluation of Cases Over a 6-Year Period from a Regional UK CentreEndocrine, 2018. Cited by 18 articles.

Amiodarone-Induced Thyroid Dysfunction: A Clinical UpdateExperimental and Clinical Endocrinology & Diabetes, 2018. Cited by 22 articles.

Alpha-cells: Its Role as the Islet HarmonizerInternational Journal of Diabetes and Endocrinology, 2019. Cited by 5 articles.

Senescence and Diabetes: A Mini ReviewEC Endocrinology and Metabolic Research, 2020. Cited by 8 articles.

Hyponatraemic Seizure Secondary to Primary Polydipsia Following Urological SurgeryBMJ Case Reports, 2022. Cited by 2 articles.

Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care – Real World Multicentre ExperienceCureus, 2022. Cited by 4 articles.

Conclusion:

Mohamed Nabil Elnaggar is a highly deserving candidate for the Best Researcher Award based on his substantial contributions to the fields of diabetes, endocrinology, and lipidology. His extensive education, substantial clinical experience, and significant involvement in research and teaching position him as a leader in his field. Addressing the identified areas for improvement, such as increasing publication impact and diversifying research topics, could further strengthen his candidacy and amplify his contributions to medical science. Overall, Mohamed’s achievements and ongoing efforts make him an excellent candidate for the award.

Rosalinda Madonna | Cardiovascular diseases | Women Researcher Award

Prof. Rosalinda Madonna | Cardiovascular diseases | Women Researcher Award

Associate Professor, MD PhD | University of Pisa, Azienda Ospedaliera Universitaria Pisana |  Italy

Based on the provided information about Rosalinda Madonna, here’s an assessment of her suitability for the Research for Women Researcher Award, focusing on her strengths, areas for improvement, and a conclusion:

Strengths for the Award

  1. Extensive Research Experience: Rosalinda Madonna’s extensive research background, spanning several high-impact projects, demonstrates her depth of knowledge and leadership in cardiology and molecular medicine. Her involvement as a principal investigator in numerous grants, including NIH, Department of Defense, and PRIN, highlights her ability to secure funding and lead significant research initiatives.
  2. Diverse and Impactful Research Topics: Her work covers a broad range of topics, from stem cells in diabetes to the molecular mechanisms of cardiovascular diseases and pulmonary arterial hypertension. This diversity showcases her versatility and commitment to advancing medical science.
  3. International Recognition and Collaboration: Madonna’s research has earned her international recognition and collaborative opportunities, including roles at prominent institutions in the U.S. and Italy. Her citation index (H-index from Scopus: 46; Google Scholar: 54) reflects the high impact and relevance of her work.
  4. Publication Record: With numerous publications in notable books and peer-reviewed journals, her contributions to the field are well-documented and influential. Her publications address critical issues in cardiovascular health, stem cell research, and gene expression.
  5. Leadership in Research Initiatives: As a Principal Investigator in multiple ongoing and completed projects, Madonna has demonstrated leadership in shaping research agendas and fostering innovation.

Areas for Improvement

  1. Broader Impact Metrics: While her citation indices are strong, more emphasis on the real-world impact of her research could strengthen her profile. Including specific examples of how her findings have influenced clinical practice or policy could enhance her application.
  2. Interdisciplinary Integration: Although Madonna has made significant strides in cardiology and molecular medicine, exploring interdisciplinary collaborations beyond these fields might open new avenues for impactful research.
  3. Public Engagement and Outreach: Increasing engagement with the public and broader scientific community through public talks, media, or outreach programs could enhance the visibility of her work and its societal impact.
  4. Mentorship and Training: Providing more information on her role in mentoring young researchers and her contributions to educational programs would add depth to her profile, highlighting her influence on the next generation of scientists.

Conclusion

Rosalinda Madonna is a highly qualified candidate for the Research for Women Researcher Award. Her extensive research experience, significant contributions to cardiology and molecular medicine, international recognition, and robust publication record underscore her suitability for this award. Addressing areas such as broader impact metrics, interdisciplinary integration, public engagement, and mentorship could further enhance her profile. Overall, her impressive achievements and ongoing research make her a standout candidate for recognition in this prestigious award.

Short Bio:

Rosalinda Madonna is an Associate Professor of Cardiology at the University of Pisa. With a robust career spanning from research fellowships in the U.S. to leading a Molecular Cardiology Laboratory in Italy, she is renowned for her work in cardiovascular diseases and molecular cardiology.

Profile

ORCID

Education:

Rosalinda Madonna has a comprehensive educational background in cardiology and molecular medicine, bolstered by her research fellowships at esteemed institutions such as the University of Texas Medical School and University of Louisville.

Experience:

Madonna’s career includes pivotal roles such as Research Scientist at the Texas Heart Institute and Adjunct Assistant Professor in Cardiology at the University of Texas Medical School. She currently leads the Molecular Cardiology Laboratory and outpatient clinic at the University of Pisa.

Research Interests:

Her research focuses on molecular mechanisms in cardiovascular diseases, stem cells, and pulmonary arterial hypertension. She investigates novel therapeutic targets and pathophysiological mechanisms in these areas.

Awards:

Rosalinda Madonna has received multiple prestigious awards and grants, including from the NIH, Department of Defense, and MIUR, reflecting her significant contributions and impact in her field.

Publications:

De Caterina R, Madonna R, Hassan J, Procopio AD (2001). “Nutrients and gene expression.” World Review of Nutrition and Dietetics, vol. 89, pp. 23-52.

Madonna R, Torge G, Di Napoli P, De Caterina R (2002). “La Sindrome da basse HDL.” I Quaderni del CNR, pp. 92-101.

Zampolli A, Madonna R, De Caterina R (2002). “Altri fattori di rischio.” I Quaderni del CNR, pp. 162-181.

De Caterina R, Madonna R (2005). “Role of Nutrients and physical activity in gene expression.” World Review of Nutrition and Dietetics, vol. 94, pp. 107-119.

Geng YJ, Madonna R (2005). “Stem Cells in Atherosclerosis.” Current Topics in Atherosclerosis Research, pp. 147-164.

Madonna R, De Caterina R (2007). “Homocysteine and endothelial dysfunction.” Cardiology Research and Clinical Developments, pp. 129-139.

Geng YJ, Madonna R (2007). “Stem Cells in Atheriosclerosis and Atherosclerosis-related vascular disorders.” Endothelial Dysfunctions and Vascular Disease.

Madonna R, De Caterina R (2011). “Cell-Based Gene Therapies and Stem Cells for Regeneration of Ischemic Tissues.” Gene Therapy Applications, pp. 17-34.

Madonna R, De Caterina R (2012). “Tissue-specific progenitor cells.” Progenitor and Stem Cell Technologies and Therapies, pp. 237-262.